Kerry–Lee Milner

1.3k total citations
13 papers, 1.0k citations indexed

About

Kerry–Lee Milner is a scholar working on Neurology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kerry–Lee Milner has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 6 papers in Physiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kerry–Lee Milner's work include Botulinum Toxin and Related Neurological Disorders (6 papers), Pain Mechanisms and Treatments (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Kerry–Lee Milner is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (6 papers), Pain Mechanisms and Treatments (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Kerry–Lee Milner collaborates with scholars based in Australia, United Kingdom and Hong Kong. Kerry–Lee Milner's co-authors include Donald J. Chisholm, Jacob George, David van der Poorten, James G. Kench, Michael I. Trenell, Alexander Hodge, Roslyn M. London, Jason M. Hui, Jerry R. Greenfield and Dorit Samocha‐Bonet and has published in prestigious journals such as Gastroenterology, Hepatology and Endocrine Reviews.

In The Last Decade

Kerry–Lee Milner

13 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerry–Lee Milner Australia 8 676 304 299 217 176 13 1.0k
Rochelle Collantes United States 13 938 1.4× 332 1.1× 195 0.7× 378 1.7× 188 1.1× 19 1.1k
Halil Genç Türkiye 17 557 0.8× 253 0.8× 146 0.5× 103 0.5× 214 1.2× 35 889
Fabio Mecca Italy 7 611 0.9× 392 1.3× 130 0.4× 136 0.6× 154 0.9× 7 790
Francesca Ragogna Italy 18 878 1.3× 667 2.2× 500 1.7× 177 0.8× 429 2.4× 30 1.6k
Hazem Elariny United States 18 1.1k 1.7× 461 1.5× 323 1.1× 308 1.4× 256 1.5× 26 1.5k
Marko Duvnjak Croatia 13 434 0.6× 227 0.7× 119 0.4× 171 0.8× 64 0.4× 56 825
Grégory Baud France 13 518 0.8× 408 1.3× 315 1.1× 128 0.6× 88 0.5× 38 1.0k
Vincenzo Citro Italy 14 450 0.7× 128 0.4× 122 0.4× 237 1.1× 50 0.3× 26 729
V. Ponti Italy 10 843 1.2× 366 1.2× 167 0.6× 97 0.4× 87 0.5× 15 1.1k
Laura Bertoccini Italy 18 345 0.5× 291 1.0× 205 0.7× 47 0.2× 108 0.6× 38 910

Countries citing papers authored by Kerry–Lee Milner

Since Specialization
Citations

This map shows the geographic impact of Kerry–Lee Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry–Lee Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry–Lee Milner more than expected).

Fields of papers citing papers by Kerry–Lee Milner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry–Lee Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry–Lee Milner. The network helps show where Kerry–Lee Milner may publish in the future.

Co-authorship network of co-authors of Kerry–Lee Milner

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry–Lee Milner. A scholar is included among the top collaborators of Kerry–Lee Milner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry–Lee Milner. Kerry–Lee Milner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tummanapalli, Shyam Sunder, Tushar Issar, Ann M. Poynten, et al.. (2025). Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes. Diabetologia. 68(6). 1329–1334. 2 indexed citations
2.
Issar, Tushar, et al.. (2024). Impact of glucagon-like peptide-1 receptor agonists on axonal function in diabetic peripheral neuropathy. Journal of Neurophysiology. 133(1). 14–21. 4 indexed citations
3.
Issar, Tushar, et al.. (2024). Progression of axonal excitability abnormalities with increasing clinical severity of diabetic peripheral neuropathy. Clinical Neurophysiology. 160. 12–18. 1 indexed citations
4.
Issar, Tushar, et al.. (2024). Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy. Diabetologia. 67(3). 561–566. 22 indexed citations
5.
Issar, Tushar, et al.. (2024). Evaluation of the Impact of Advanced Glycation End-Products on Peripheral Neuropathy Outcomes in Type 2 Diabetes. Biomedicines. 12(11). 2518–2518. 3 indexed citations
6.
Issar, Tushar, et al.. (2024). Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study. Diabetes. 73(11). 1875–1882. 7 indexed citations
7.
Issar, Tushar, et al.. (2022). Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes. European Journal of Neurology. 29(12). 3571–3579. 12 indexed citations
8.
Issar, Tushar, Natalie Kwai, Ann M. Poynten, et al.. (2021). Effect of exenatide on peripheral nerve excitability in type 2 diabetes. Clinical Neurophysiology. 132(10). 2532–2539. 15 indexed citations
9.
Hocking, Samantha, Dorit Samocha‐Bonet, Kerry–Lee Milner, Jerry R. Greenfield, & Donald J. Chisholm. (2013). Adiposity and Insulin Resistance in Humans: The Role of the Different Tissue and Cellular Lipid Depots. Endocrine Reviews. 34(4). 463–500. 203 indexed citations
10.
Milner, Kerry–Lee, David van der Poorten, Michael I. Trenell, et al.. (2009). Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance. Gastroenterology. 138(3). 932–941.e3. 103 indexed citations
11.
Milner, Kerry–Lee, David van der Poorten, Aimin Xu, et al.. (2009). Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease†. Hepatology. 49(6). 1926–1934. 147 indexed citations
12.
Poorten, David van der, Kerry–Lee Milner, Jason M. Hui, et al.. (2008). Visceral fat. Hepatology. 48(2). 449–457. 468 indexed citations
13.
Heilbronn, Leonie K., Kerry–Lee Milner, Adamandia D. Kriketos, Janice Russell, & Lesley V. Campbell. (2007). Metabolic dysfunction in anorexia nervosa. Obesity Research & Clinical Practice. 1(2). 139–146. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026